ClinicalTrials.gg
Sign In

Macular dystrophy, corneal type 1 clinical trials

The registry lists 22 studies for Macular dystrophy, corneal type 1 across more than 10 countries. 9 are recruiting or about to start. 4 of them are mainly about Macular dystrophy, corneal type 1 (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Macular dystrophy, corneal type 1 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting
9
Completed
9
Active, not recruiting
2
Withdrawn
1
Status unknown
1

Phase

Phase 2
8
Phase 3
1
Phase 1
1

Where

United States
16
Germany
3
Canada
3
China
2
Australia
2
Netherlands
2

Who runs them

University of Michigan (4) · University of Pennsylvania (3) · Cedars-Sinai Medical Center (2) · National Cancer Institute (NCI) (1) · National Human Genome Research Institute (NHGRI) (1) · Consun Pharmaceutical Group (1) · Prof. Dr. Paul Brinkkoetter (1) · Nanjing University School of Medicine (1)

What is being tested here

Drugs under test in Macular dystrophy, corneal type 1 studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
N-acetylmannosamine101
TACI receptor-IgG Fc fragment fusion protein101
Sparsentan101
Rituximab002
Prednisone002
Sirolimus002
Etoposide001
Interferon Alpha001
Zidovudine001
Liposomal doxorubicin001

Drug classes tested here Corticosteroids 3

Coming up

0phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 9 Macular dystrophy, corneal type 1 studies recruiting now, 4 (44%) set no upper age limit and 2 (22%) stop at 75 or younger. 7 (78%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (11%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
107 (78%)7 (78%)
188 (89%)8 (89%)
308 (89%)8 (89%)
408 (89%)8 (89%)
508 (89%)8 (89%)
657 (78%)7 (78%)
757 (78%)7 (78%)
855 (56%)5 (56%)

Across all 22 studies, recruiting or not: 14% stop at 75 or younger and 14% at 65; 59% take children; 5% are for women only and 0% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 22 of 22. search them.